Clinical Trial Update: Nasal Potential Studies Utilizing Cystic Fibrosis Transmembrane Regulator (CFTR) Modulators [Phase 2]

View source ↗

Summary

This update summarizes Phase 2 nasal potential studies using CFTR modulators for cystic fibrosis; the trial status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cystic Fibrosis

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Cystic Fibrosis | Phase 2 | Status: COMPLETED